With repeated use, the brain becomes accustomed to this artificial inhibition. That cycle of sleeplessness relieved by pills ...

Neurelis, Inc., today announced it will present at the Alliance to Cure Cavernous Malformation (CCM) 21st International CCM Scientific & Clinical Meeting to be held November 6-7, 2025, in Atlanta, ...

Dominic Cipriano couldn't stop shaking. A drug dealer on the streets of Kensington had sold him a bag of what he thought was ...

By last winter, medetomidine was showing up in 70% of illicit opioid samples tested in Philly, along with other unregulated ...

Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced it will join the epilepsy community at the 13th Annual Sofie's Journey Epilepsy Awareness Day & Education Expo at ...

Topical corticosteroids are recommended as first-line treatment for all levels of atopic dermatitis, as well as for ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Opioid deprescribing is advised when risks of opioid use outweigh benefits. A tailored, patient-centered plan with gradual dose reduction, monitoring, and support can improve outcomes and reduce harm.

Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, marketing, and the impact of technology on contemporary arts and culture.

12:50, Sat, Oct 18, 2025 Updated: 13:06, Sat, Oct 18, 2025 Speculation around the tax changes Chancellor Rachel Reeves might unveil in her Autumn Budget on November 26 has had a noticeable impact on ...